Skip to main content

. 1981 Jul 25;283(6286):278. doi: 10.1136/bmj.283.6286.278

Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics.

E A Ward, G M Ward, R C Turner

PMCID: PMC1506311 PMID: 6788293

278

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Kuzuya H., Blix P. M., Horwitz D. L., Steiner D. F., Rubenstein A. H. Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes. 1977 Jan;26(1):22–29. doi: 10.2337/diab.26.1.22. [DOI] [PubMed] [Google Scholar]
Ludvigsson J., Heding L. G., Larsson Y., Leander E. C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control. Acta Paediatr Scand. 1977 Mar;66(2):177–184. doi: 10.1111/j.1651-2227.1977.tb07830.x. [DOI] [PubMed] [Google Scholar]
Phillips M., Simpson R. W., Holman R. R., Turner R. C. A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements. Q J Med. 1979 Jul;48(191):493–506. [PubMed] [Google Scholar]
Prince M. J., Olefsky J. M. Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors. J Clin Invest. 1980 Sep;66(3):608–611. doi: 10.1172/JCI109894. [DOI] [PMC free article] [PubMed] [Google Scholar]
Yue D. K., Baxter R. C., Turtle J. R. C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus. Metabolism. 1978 Jan;27(1):35–44. doi: 10.1016/0026-0495(78)90121-x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES